Print

JT And Torii Pharmaceutical Co. To Launch New HIV Treatment Drug In Japan 
10/19/2005 5:10:43 PM

Japan Tobacco Inc. (JT) (TSE: 2914) and Torii Pharmaceutical Co., Ltd. (TSE: 4551), JT's pharmaceutical business subsidiary, announced today that the companies would launch the HIV treatment drug "Viread(R) Tab. 300mg" (generic name: Tenofovir Disoproxil Fumarate), licensed by Gilead Sciences, Inc. (Gilead) (Nasdaq: GILD), starting April 12 in Japan.
//-->